Centerview SF Biotech - Quality of Exits?
Obviously CVP is known for retaining bankers - but for those in the healthcare SF group, what are the quality of exits? Do analysts have to network on their own or do headhunters help with healthcare-specific roles? Do analysts get looks at biotech crossover/hedge funds?
Quality is on par with other EBs but like you said, they’re just naturally less of them due to people taking A2As. You’re not going to get more or less attention from HH if that’s your concern
Quidem vitae similique sapiente nobis accusamus qui. Ea iure est qui ut aut. Fugit mollitia veritatis tenetur at ut. Eaque labore possimus eveniet. Dolores nostrum molestiae qui beatae. Quis corrupti culpa dolor omnis tenetur et necessitatibus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...